Trial tests Gadolinium-Free MRI dye to spot brain tumors and MS lesions
NCT ID NCT06322342
Summary
This study tested a new type of MRI contrast dye called RVP-001, which is based on manganese instead of the commonly used gadolinium. It involved 18 adults with known brain or spinal cord lesions from conditions like tumors or multiple sclerosis. The main goal was to see if RVP-001 was safe and if it could make lesions show up as clearly on MRI scans as the standard gadolinium-based dyes do.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
University of Missouri
Columbia, Missouri, 65212, United States
-
Yale New Haven Hospital
New Haven, Connecticut, 06510, United States
Conditions
Explore the condition pages connected to this study.